Nabulsi Azmi 4
4 · Phathom Pharmaceuticals, Inc. · Filed Jul 17, 2023
Insider Transaction Report
Form 4
Nabulsi Azmi
Chief Operating Officer
Transactions
- Award
Common Stock
2023-07-14+110,000→ 209,567 total - Disposition to Issuer
Stock Option
2023-07-14−150,000→ 0 totalExercise: $39.11Exp: 2031-01-27→ Common Stock (150,000 underlying) - Disposition to Issuer
Stock Option
2023-07-14−70,000→ 0 totalExercise: $32.20Exp: 2030-06-30→ Common Stock (70,000 underlying)
Holdings
- 785,700(indirect: By Trust)
Common Stock
- 3,578.93(indirect: By 401(k))
Common Stock
Footnotes (2)
- [F1]On July 14, 2023, the Issuer canceled, pursuant to the Issuer's option exchange program, options to purchase 220,000 shares of common stock of the Issuer and in exchange issued to the Reporting Person 110,000 restricted stock units, each of which represents a contingent right to receive one share of the Issuer's common stock.
- [F2]Includes 1,233.71 shares acquired under the Phathom Pharmaceuticals, Inc. 401(k) plan.